Efficacy and safety of mesenchymal stromal cells in preclinical models of acute lung injury: a systematic review protocol — Manoj M. Lalu (2014) | RDL Network
The results of this systematic review will comprehensively summarize the safety and efficacy of MSC therapy in preclinical models of acute lung injury. Our results will help translational scientists and clinical trialists to determine whether sufficient evidence exists to perform a human clinical trial. These results may also guide future acute lung injury preclinical and clinical research.
Carly C. Barron, Manoj M. Lalu, Duncan J. Stewart, Dean Fergusson, Homer Yang, David Moher, Peter Liu, C. David Mazer, P.J. Devereaux, Lauralyn McIntyre
Lauralyn McIntyre, David Moher, Dean Fergusson, Katrina Sullivan, Shirley H. J. Mei, Manoj M. Lalu, John C. Marshall, Malcolm D. McLeod, Gilly Griffin, Jeremy Grimshaw, Alexis F. Turgeon, Marc T. Avey, Michael A. Rudnicki, M R Hadian Jazi, Jason Fishman, Duncan J. Stewart
.webp){kind=small}
Discussion(0)
No comments yet. Be the first to comment.